Aliases & Classifications for Color Blindness

About this section

Aliases & Descriptions for Color Blindness:

Name: Color Blindness 11 50 38 13 68
Colour Vision Deficiency 11
Color Vision Defect 68
 
Colour Blindness 11
Blindness Color 11

Classifications:



External Ids:

Disease Ontology11 DOID:13399
ICD1030 H53.5, H53.50
ICD9CM32 368.5
MeSH39 D003117
NCIt45 C3891

Summaries for Color Blindness

About this section
MedlinePlus:38 Most of us see our world in color. we enjoy looking at a lush green lawn or a red rose in full bloom. if you have a color vision defect, you may see these colors differently than most people. there are three main kinds of color vision defects. red-green color vision defects are the most common. this type occurs in men more than in women. the other major types are blue-yellow color vision defects and a complete absence of color vision. most of the time, color blindness is genetic. there is no treatment, but most people adjust and the condition doesn't limit their activities.

MalaCards based summary: Color Blindness, also known as colour vision deficiency, is related to colorblindness, deutan and blue color blindness, and has symptoms including photophobia, visual disturbance and other specified visual disturbances. An important gene associated with Color Blindness is OPN1SW (Opsin 1, Short Wave Sensitive), and among its related pathways are Metabolism of fat-soluble vitamins and Retinoid cycle disease events. Affiliated tissues include testes, eye and liver, and related mouse phenotypes are Decreased shRNA abundance (Z-score < -2) and vision/eye.

Disease Ontology:11 A blindness that is characterized by the inability or decreased ability to see color, or perceive color differences, under normal lighting conditions.

Wikipedia:71 Color blindness, also known as color vision deficiency, is the decreased ability to see color or... more...

Related Diseases for Color Blindness

About this section

Diseases in the Color Blindness family:

Acquired Color Blindness

Diseases related to Color Blindness via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 46)
idRelated DiseaseScoreTop Affiliating Genes
1colorblindness, deutan31.7CNGB3, OPN1LW
2blue color blindness12.2
3red-green color blindness12.2
4red color blindness12.2
5acquired color blindness12.1
6color vision deficiency11.7
7achromatopsia11.7
8colorblindness, tritan11.6
9blue cone monochromacy11.1
10red-green color vision defects11.1
11achromatopsia-211.0
12colorblindness, protan11.0
13achromatopsia 710.7
14hypogonadotropic hypogonadism 1 with or without anosmia10.7
15stxbp1 encephalopathy with epilepsy10.2OPN1LW, OPN1MW
16inflammatory bowel disease 2010.1CNGA3, CNGB3
17retinitis pigmentosa 3410.1CNGB3, OPN1MW
18lipoprotein lipase deficiency10.1CNGB3, OPN1SW
19dystonia 1610.1CNGA3, CNGB3
20somatization disorder10.1CNGB3, OPN1LW, OPN1MW
21lumbosacral plexus lesion10.1CNGB3, OPN1LW, OPN1MW
22yellow fever10.0CNGA3, GNAT2
23lacrimal duct defect10.0CNGA3, CNGB3, GNAT2
24adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency10.0CNGA3, CNGB3, GNAT2
25waisman syndrome10.0CNGA3, CNGB3, OPN1LW, OPN1MW
26retinitis pigmentosa 199.9CNGB3, GNAT2
27celiac disease 89.9CNGA3, CNGB3, MFRP
28familial isolated restrictive cardiomyopathy9.8CNGA3, CNGB3, GNAT2, PDE6C
29arthrogryposis, distal, type 2a9.8CNGA3, CNGB3, GNAT2, PDE6C
30cerebritis9.7
31night blindness9.7
32lipoyltransferase 1 deficiency9.6CNGA3, CNGB3, CNNM4, GNAT2, PDE6C
33prostate cancer9.5
34hemophilia a9.5
35amblyopia9.5
36prostatitis9.5
37hemoglobinopathy9.5
38retinitis9.5
39refractive error9.5
40muscular dystrophy9.5
41albinism9.5
42hemophilia9.5
43progressive muscular dystrophy9.5
44glioblastoma classical subtype9.3CNGB3, MFRP, OPN1LW, OPN1MW, PDE6C, PDE6H
45acute erythroid leukemia8.7CNGA3, CNGB3, CNNM4, GNAT2, MFRP, OPN1LW
46angioid streaks8.4CNGA3, CNGB3, CNNM4, F9, G6PD, GNAT2

Graphical network of the top 20 diseases related to Color Blindness:



Diseases related to color blindness

Symptoms & Phenotypes for Color Blindness

About this section

UMLS symptoms related to Color Blindness:


photophobia, visual disturbance, other specified visual disturbances, subjective visual disturbance, unspecified

GenomeRNAi Phenotypes related to Color Blindness according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-8410.1CNNM4, OPN1LW, OPN1MW

MGI Mouse Phenotypes related to Color Blindness according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053916.3CNGA3, CNGB3, CNNM4, GNAT2, MFRP, OPN1LW

Drugs & Therapeutics for Color Blindness

About this section

Drugs for Color Blindness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 58)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
RanibizumabapprovedPhase 4486347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
2Angiogenesis InhibitorsPhase 44257
3Angiogenesis Modulating AgentsPhase 44185
4
EplerenoneapprovedPhase 2, Phase 396107724-20-9150310, 443872
Synonyms:
107724-20-9
7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone
AC-4213
AC1L9FDC
C12512
CGP-30083
CHEBI:31547
CHEBI:726453
CHEMBL1095097
CID443872
D01115
Eplerenone
 
Eplerenone (JAN/USAN/INN)
Epoxymexrenone
Inspra
Inspra (TN)
Inspra, Epoxymexrenone, CGP30083, SC-66110,Eplerenone
MolPort-003-986-216
NCGC00159559-01
NCGC00159559-02
S1707_Selleck
SC-66110
Selara
TL8000270
ZINC03985982
5
SpironolactoneapprovedPhase 2, Phase 32321952-01-7, 52-01-75833
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
496916-40-6
52-01-7
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
AB00513806
AC-4214
AC1L1L8Q
Abbolactone
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
Cardel Brand of Spironolactone
D00443
D013148
DB00421
Deverol
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona Alter
Espironolactona Mundogen
Espironolactona [INN-Spanish]
Euteberol
Flumach
Frumikal
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
HSDB 3184
Hormosan Brand of Spironolactone
I06-1970
Jenapharm Brand of Spironolactone
Jenaspiron
LS-118614
LT00772287
Lacalmin
Lacdene
Laractone
MLS001074672
MLS001333253
MLS001333254
MLS002153245
MLS002207058
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
 
NCGC00164397-02
NSC 150399
NSC150399
Nefurofan
Novo Spiroton
Novo-Spiroton
NovoSpiroton
Novopharm Brand of Spironolactone
Osyrol
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche Brand of Spironolactone
S0260
S3378_SIGMA
SAM002264648
SC 9420
SC-9420
SC9420
SMR000471892
SNL
SPBio_002115
Sagisal
Searle Brand of Spironolactone
Sincomen
Spiractin
Spiresis
Spiretic
Spiridon
Spiro L.U.T.
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro-Tablinen
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono Isis
Spirono-Isis
Spironocompren
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone A
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Xenalon
ZINC03861599
betapharm Brand of Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
spiro von ct
spironolactone
spironolattone
von ct, spiro
6Natriuretic AgentsPhase 2, Phase 31697
7diureticsPhase 2, Phase 31418
8Diuretics, Potassium SparingPhase 2, Phase 31917
9Mineralocorticoid Receptor AntagonistsPhase 2, Phase 3346
10MineralocorticoidsPhase 2, Phase 3367
11HormonesPhase 2, Phase 314415
12Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 2, Phase 313168
13Hormone AntagonistsPhase 2, Phase 313180
14
Valproic Acidapproved, investigationalPhase 232799-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propyl-pentanoic acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VPA
Valcote
Valparin
Valproate
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
acide valproïque
acidum valproicum
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
ácido valproico
15Psychotropic DrugsPhase 26430
16Tranquilizing AgentsPhase 24265
17Neurotransmitter AgentsPhase 2, Phase 118340
18Antimanic AgentsPhase 2814
19GABA AgentsPhase 21684
20AnticonvulsantsPhase 22695
21Central Nervous System DepressantsPhase 213403
22
ClemastineapprovedPhase 1815686-51-826987
Synonyms:
(+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
(+)-(2R)-2-(2-(((R)-p-chloro-α-methyl-α-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
(+)-(2R)-2-[2-[[(R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine
(+)-(2R)-2-[2-[[(R)-p-chloro-α-methyl-α-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine
(2R)-2-(2-{[(1R)-1-(4-chlorophenyl)-1-phenylethyl]oxy}ethyl)-1-methylpyrrolidine
(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
(2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine
14976-57-9
15686-51-8
2(R)-[2-[(1R)-(4-Chlorophenyl)-1-phenyl-ethoxy]ethyl-1-methylpyrrolidine
2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin
AC1L1CAE
AC1Q3N52
BIDD:GT0391
BPBio1_000300
BRD-K30240666-051-05-0
BSPBio_000272
BSPBio_002045
C21H26ClNO
CAS-14976-57-9
CHEBI:3738
CHEMBL1626
CID26987
CLEMASTINE FUMARATE
Clemastina
Clemastina [INN-Spanish]
Clemastine Fumarate
Clemastine [USAN:BAN]
Clemastinum
Clemastinum [INN-Latin]
DB00283
 
DivK1c_000285
HMS2089I22
HS 592
HS-592
IDI1_000285
KBio1_000285
KBio3_001265
KBioGR_001570
LS-137531
Lopac-C-8903
Meclastin
Meclastine
Mecloprodin
NCGC00015281-01
NCGC00016710-01
NCGC00025168-01
NINDS_000285
Prestwick0_000306
Prestwick1_000306
Prestwick2_000306
Prestwick3_000306
SPBio_000817
SPBio_002491
Spectrum2_000689
Spectrum3_000353
Spectrum4_000955
Spectrum5_001520
Tavegyl
Tavist
Tavist (*Fumarate*)
Tocris-1453
UNII-95QN29S1ID
clemastine
23
Histamineapproved, investigationalPhase 1105075614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-(4-imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
4-imidazoleethylamine
5-Imidazoleethylamine
5-imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminoethylglyoxaline
beta-aminoethylimidazole
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
24Histamine AntagonistsPhase 1961
25Histamine H1 AntagonistsPhase 1791
26
Histamine PhosphatePhase 1104951-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
27Dermatologic AgentsPhase 15806
28Anti-Allergic AgentsPhase 11522
29AntipruriticsPhase 1841
30
Epinephrineapproved, vet_approved98551-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
31
Latanoprostapproved, investigational198130209-82-45282380, 5311221
Synonyms:
130209-82-4
AC1NSK8Q
AR-202
Ambap130209-82-4
CHEBI:6384
CHEMBL1051
CID5311221
CPD000466354
Catioprost
D00356
HMS2051H11
HMS2089J17
Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate
Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
Jsp001835
L1167_SIGMA
Latanoprost
Latanoprost (JAN/USAN/INN)
Latanoprostum
MLS000759468
MLS001424106
 
MolPort-003-942-862
Nova-21027
PHXA-41
PhXA 41
PhXA34 [as 15(R,S)-isomer]
PhXA41
Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
S1254_Selleck
SAM001246671
SMR000466354
TL8000716
XA-41
XA41
Xalatan
Xalatan (TN)
Xalatan Fixed Flow Device
ZINC12468792
isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate
latanoprost
latanoprost free acid
propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
32
Timololapproved25226839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
 
NCGC00016038-02
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol anhydrous
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptol
Tocris-0649
UNII-817W3C6175
timolol
33
Levodopaapproved40259-92-76047
Synonyms:
(-)-(3,4-Dihydroxyphenyl)alanine
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(-)-3-(3,4-dihydroxyphenyl)-L-alanine
(-)-Dopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(−)-3-(3,4-dihydroxyphenyl)-L-alanine
(−)-dopa
.Beta.-(3, 4-Dihydroxyphenyl)alanine
.Beta.-(3,4-Dihydroxyphenyl)-L-alanine
1E83F927-C221-46AA-B90A-81B33C5F3868
2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
23734-74-9
25525-15-9
3, 4-Dihydroxy-L-phenylalanine
3, 4-Dihydroxyphenylalanine
3,4-DIHYDROXYPHENYLALANINE
3,4-Dihydroxy-L-phenylalanine
3,4-Dihydroxyphenyl-L-alanine
3,4-Dihydroxyphenylalanine
3,4-Dihydroxyphenylalanine (VAN)
3,4-dihydroxy-L-phenylalanine
3,4-dihydroxyphenylalanine
3-(3,4-Dihydroxypheny
3-(3,4-Dihydroxyphenyl)-L-alanine
3-Hydroxy-L-tyrosine
34241-25-3
37830_FLUKA
587-45-1
59-92-7
72572-99-7
72573-00-3
88250-23-1
90638-38-3
AC-11686
AC1L1LOR
AC1Q4U7F
BIDD:GT0158
BPBio1_000059
BSPBio_000053
BSPBio_002354
Bendopa
Bio-0575
Biodopa
Brocadopa
C00355
C9H11NO4
CAS-59-92-7
CCRIS 3766
CHEBI:15765
CHEMBL1009
CID6047
Cerepap
Cidandopa
D 9628
D00059
D0600
D9628
D9628_SIGMA
DAH
DB01235
DOPA
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
DivK1c_000452
Dopa
Dopaflex
Dopaidan
Dopal
Dopal-Fher
Dopal-fher
Dopalina
Dopar
Dopar (TN)
Doparkine
Doparl
Dopasol
Dopaston
Dopaston SE
Dopastone
Dopastral
Dopicar
Doprin
EINECS 200-445-2
EU-0100454
Eldopal
Eldopar
Eldopatec
Eurodopa
HMS1568C15
HMS1922J14
HMS2090O08
HMS2093N04
HMS501G14
HSDB 3348
Helfo DOPA
 
Helfo-Dopa
Helfo-dopa
IDI1_000452
IV Levodopa
InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14
Insulamina
KBio1_000452
KBio2_000934
KBio2_003502
KBio2_006070
KBioGR_001177
KBioSS_000934
L Dopa
L(-)-Dopa
L-(-)-Dopa
L-(3, 4-Dihydroxyphenyl)-.alpha.-alani
L-(3, 4-Dihydroxyphenyl)alanine
L-(o-Dihydroxyphenyl)alanine
L-.Beta.-(3,4-Dihydroxyphenyl)alanine
L-3,4-Dihydroxyphenylalanine
L-3,4-dihydroxyphenylalanine
L-3-(3,4-Dihydroxyphenyl)-Alanine
L-3-(3,4-Dihydroxyphenyl)alanine
L-3-Hydroxytyrosine
L-4-5-Dihydroxyphenylalanine
L-DOPA
L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa
L-Dihydroxyphenylalanine
L-Dopa
L-O-Dihydroxyphenylalanine
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-o-Hydroxytyrosine
LS-255
Laradopa
Larodopa
Ledopa
Levedopa
Levodopa
Levodopa (JP15/USP)
Levodopa (JP15/USP/INN)
Levodopa [USAN:INN:BAN:JAN]
Levodopum
Levodopum [INN-Latin]
Levopa
Lopac-D-9628
Lopac0_000454
MLS000028514
Maipedopa
MolPort-000-856-937
NCGC00015384-01
NCGC00016270-01
NCGC00016270-06
NCGC00093869-04
NINDS_000452
NSC 118381
NSC118381
PDSP1_001541
PDSP2_001525
Parda
Pardopa
Prestwick0_000017
Prestwick1_000017
Prestwick2_000017
Prestwick3_000017
Prestwick_185
Prodopa
Ro 4-6316
S1726_Selleck
SDCCGMLS-0066924.P001
SMR000058312
SPBio_000391
SPBio_001974
SPECTRUM2300205
Sobiodopa
Spectrum2_000496
Spectrum4_000539
Spectrum5_001899
Spectrum_000454
Syndopa
UNII-46627O600J
Veldopa
Weldopa
b-(3,4-Dihydroxyphenyl)-L-alanine
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)alanine
bmse000322
component of Sinemet
l)-L-alanine
nchembio.2007.55-comp26
nchembio.89-comp9
ne
β-(3,4-dihydroxyphenyl)alanine
34
Bevacizumabapproved, investigational2020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
35
Luteinapproved, nutraceutical71127-40-26433159, 5368396
Synonyms:
(3R,3'R)-beta,beta-Carotene-3,3'-Diol, Lutein
(3R,3'R,6'R)-Lutein
(3R,3'R,6S)-4,5-Didehydro-5,6-Dihydro-beta,beta-Carotene-3,3'-Diol
3,3'-Dihydroxy-alpha-carotene
4,5-Didehydro-5,6-dihydro-beta,beta-carotene-3,3'-diol
All-trans-(+)-Xanthophyll
All-trans-Lutein
All-trans-Xanthophyll
 
Bo-Xan
Lutein
Lutein ester
Luteine
Phylloxanthin
Vegetable lutein
Vegetable luteol
beta,epsilon-Carotene-3,3'-diol
trans-Lutein
36
Maleic acidexperimental296110-16-7444266
Synonyms:
(2Z)-2-Butenedioate
(2Z)-2-Butenedioic acid
(2Z)-Butene-2-dioate
(2Z)-Butene-2-dioic acid
(2Z)-but-2-enedioate
(2Z)-but-2-enedioic acid
(Z)-2-Butenedioate
(Z)-2-Butenedioic acid
(z)-butenedioate
(z)-butenedioic acid
2-Butenedioate
2-Butenedioic acid
Cis-butenedioate
Cis-butenedioic acid
 
H2male
Kyselina maleinova
MAE
Maleate
Maleic acid
Maleic acid [NA2215]
Maleinic acid
Malenic acid
Malezid CM
Scotchbond multipurpose etchant
Toxilic acid
cis-1,2-Ethylenedicarboxylic acid
cis-2-Butenedioate
cis-2-Butenedioic acid
cis-But-2-enedioate
cis-But-2-enedioic acid
37Adrenergic alpha-Agonists1734
38Epinephryl borate985
39Racepinephrine985
40Adrenergic Agents5352
41Adrenergic Agonists3027
42Anti-Arrhythmia Agents3093
43Adrenergic beta-Antagonists1193
44Adrenergic Antagonists1573
45Antihypertensive Agents4207
46Brimonidine Tartrate12570359-46-5
47Adrenergic alpha-2 Receptor Agonists980
48Brimonidine Tartrate, Timolol Maleate Drug Combination24
49Dihydroxyphenylalanine143
50Endothelial Growth Factors382

Interventional clinical trials:

(show all 36)
idNameStatusNCT IDPhase
1Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisUnknown statusNCT01669447Phase 4
2A Study of the Beneficial Effects of Eplerenone on Central Serous ChorioretinopathyNot yet recruitingNCT02215330Phase 2, Phase 3
3CNTF Implants for CNGB3 AchromatopsiaCompletedNCT01648452Phase 1, Phase 2
4Trial of Oral Valproic Acid for Retinitis PigmentosaCompletedNCT01233609Phase 2
5Gene Therapy for Achromatopsia (CNGB3)RecruitingNCT03001310Phase 1, Phase 2
6Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 AchromatopsiaRecruitingNCT02599922Phase 1, Phase 2
7Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients With CNGA3-linked AchromatopsiaActive, not recruitingNCT02610582Phase 1, Phase 2
8Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 AchromatopsiaNot yet recruitingNCT02935517Phase 1, Phase 2
9Effect of Clemastine Fumarate on Color Vision in Healthy ControlsCompletedNCT02613091Phase 1
10Do Blue-Blocking Lenses Block Blue Colour From Our Lives?Unknown statusNCT00403143
11Panretinal Photo-stimulation in Proliferative Diabetic RetinopathyUnknown statusNCT02309502
12Visual Activity Evoked by Infrared in Humans After Dark AdaptationCompletedNCT02909985
13Ì-SPIES, Comparison of Cystoscopy Images in Four Different SPIES ModalitiesCompletedNCT02174302
14Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.CompletedNCT02970266
15Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)CompletedNCT02173496
16Ocular Blood Flow in Glaucoma Patients - the Leuven Eye StudyCompletedNCT01840202
17Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT00706927
18Blueberry Effects on Dark Vision and Glare RecoveryCompletedNCT01942746
19VERION Versus Conventional, Manual Ink-marking in Toric IOL ImplantationCompletedNCT02370953
20Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal DystrophyCompletedNCT00422721
21Study of the Macular Pigment by the Consumption of Corn With Strong Content in ZeaxanthineCompletedNCT02113254
22Study of Usher Syndromes, Type 1 and Type 2CompletedNCT00001347
23Evaluating Color Perception Under LED Red/Green and Green Dominant LightRecruitingNCT01927536
24Optic Neuritis and Ganglion Cell LayerRecruitingNCT02864134
25Evaluation of Different Color Vision Tests in ChildrenRecruitingNCT02464241
26Inherited Retinal Degenerative Disease RegistryRecruitingNCT02435940
27Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's PatientsRecruitingNCT02863640
28Non-invasive Optical Angiography in Age-related Macular DegenerationRecruitingNCT02521142
29Clinical and Genetic Characterization of Individuals With AchromatopsiaActive, not recruitingNCT01846052
30The Role of Macular Pigment in Patients With Age-related Macular DegenerationActive, not recruitingNCT00494325
31Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)Active, not recruitingNCT02762188
32Assessment of EyeArt as an Automated Diabetic Retinopathy Screening ToolEnrolling by invitationNCT03112005
33Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening ToolEnrolling by invitationNCT03078231
34Incidence of Dyschromatopsia in GlaucomaNot yet recruitingNCT02966678
35Prevalence of Dyschromatopsia in Glaucoma PatientsWithdrawnNCT01994564
36Risk Factors for Drusen ProgressionWithdrawnNCT01830608

Search NIH Clinical Center for Color Blindness

Genetic Tests for Color Blindness

About this section

Anatomical Context for Color Blindness

About this section

MalaCards organs/tissues related to Color Blindness:

36
Testes, Eye, Liver, Retina, Prostate

Publications for Color Blindness

About this section

Articles related to Color Blindness:

(show top 50)    (show all 188)
idTitleAuthorsYear
1
Is adding a new class of cones to the retina sufficient to cure color-blindness? (26418498)
2015
2
A review of color blindness for microscopists: guidelines and tools for accommodating and coping with color vision deficiency. (25739321)
2015
3
A Cure for Color Blindness? Stand by Buck Rogers! (26421338)
2015
4
Why racial color-blindness is myopic. (24750092)
2014
5
See no evil: Color blindness and perceptions of subtle racial discrimination in the workplace. (25111553)
2014
6
Curing Color Blindness-Mice and Nonhuman Primates. (25147187)
2014
7
Perceptions of racial confrontation: the role of color blindness and comment ambiguity. (23356360)
2013
8
Modern racism attitudes among white students: the role of dominance and authoritarianism and the mediating effects of racial color-blindness. (23057194)
2012
9
Color blindness among multiple sclerosis patients in Isfahan. (23267377)
2012
10
Prevalence of refraction errors and color blindness in heavy vehicle drivers. (22553671)
2011
11
More on color blindness. (22036741)
2011
12
General principles in motion vision: color blindness of object motion depends on pattern velocity in honeybee and goldfish. (21518470)
2011
13
Color blindness. (21774112)
2011
14
Color blindness. (20885436)
2010
15
Fuzzy-based simulation of real color blindness. (21096518)
2010
16
Color blindness and military fitness for duty: a new look at old standards. (20180475)
2010
17
Color blindness defect and medical laboratory technologists: unnoticed problems and the care for screening. (21137654)
2010
18
The incidence of color blindness among some school children of Pokhara, Western Nepal. (20677611)
2010
19
Gene therapy for color blindness. (20018970)
2009
20
On the malleability of ideology: motivated construals of color blindness. (19309207)
2009
21
Is multiculturalism or color blindness better for minorities? (19399972)
2009
22
Congenital color blindness in young Turkish men. (17464858)
2007
23
Color blindness and interracial interaction: playing the political correctness game. (17176425)
2006
24
Visual acuity and X-linked color blindness. (16133025)
2006
25
Color blindness and contrast perception in cuttlefish (Sepia officinalis) determined by a visual sensorimotor assay. (16376404)
2006
26
More on color blindness. (15789477)
2005
27
White privilege, color blindness, and services to battered women. (16043539)
2005
28
Acquired color blindness in an elderly male patient from recurrent metastatic prostate cancer. (16108957)
2005
29
Statistical and molecular analyses of evolutionary significance of red-green color vision and color blindness in vertebrates. (15647522)
2005
30
Congenital color blindness in young Turkish men. (16019694)
2005
31
Functional photoreceptor loss revealed with adaptive optics: an alternate cause of color blindness. (15148406)
2004
32
Color blindness and health care personnel. (11575992)
2001
33
Impact of color blindness on recognition of blood in body fluids. (11176773)
2001
34
Hypnotic color blindness and performance on the Stroop test. (11596828)
2001
35
Color-blindness in Calabria (Southern Italy): A north-south decreasing trend. (11534000)
2000
36
Red laser pointers and color blindness. (10076196)
1999
37
Re: Eagle Jr RC. Laser pointers and color blindness. Ophthalmology 1998; 105:760. (10076101)
1999
38
Cortical color blindness is not "blindsight for color". (9787052)
1998
39
Laser pointers and color blindness. (9593368)
1998
40
Laser pointers and color blindness. (9787345)
1998
41
Visual Pigments and Molecular Genetics of Color Blindness. (11390764)
1998
42
Complete sparing of high-contrast color input to motion perception in cortical color blindness. (10195150)
1998
43
The chemistry of John Dalton's color blindness. (7863342)
1995
44
A two-and-a-half color rainbow. Color blindness in physicians. (7980102)
1994
45
Image segmentation of a color-blindness plate. (20941227)
1994
46
Linkage of a normal personality trait to the color-blindness gene: preliminary evidence. (8274590)
1993
47
Linkage disequilibrium between glucose-6-phosphate dehydrogenase deficiency and congenital color blindness in Turkish population. (1635293)
1992
48
Bicuculline produces reversible red-green color blindness in goldfish, as revealed by monocular behavioral testing. (1663295)
1991
49
Induced color blindness in goldfish: a behavioral and electrophysiological study. (1843759)
1991
50
Ethambutol-induced color-blindness in goldfish: a behavioral, electrophysiological and morphological study. (1798615)
1991

Variations for Color Blindness

About this section

Copy number variations for Color Blindness from CNVD:

6
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
12194667127100000129200000Gain or lossOPN1SWColorblindness

Expression for genes affiliated with Color Blindness

About this section
Search GEO for disease gene expression data for Color Blindness.

Pathways for genes affiliated with Color Blindness

About this section

GO Terms for genes affiliated with Color Blindness

About this section

Cellular components related to Color Blindness according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1photoreceptor disc membraneGO:009738110.1OPN1LW, OPN1MW, OPN1SW
2transmembrane transporter complexGO:19024959.8CNGA3, CNGB3
3integral component of plasma membraneGO:00058879.5CNGA3, CNGB3, OPN1LW, OPN1MW, OPN1SW
4photoreceptor outer segmentGO:00017509.1CNGB3, GNAT2, OPN1LW, OPN1MW, OPN1SW
5photoreceptor outer segment membraneGO:00426228.8CNGA3, GNAT2, OPN1LW, OPN1MW, OPN1SW

Biological processes related to Color Blindness according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of cytokinesisGO:003246710.6OPN1LW, OPN1MW
2protein-chromophore linkageGO:001829810.3OPN1LW, OPN1MW, OPN1SW
3retinoid metabolic processGO:000152310.3OPN1LW, OPN1MW, OPN1SW
4retinal cone cell developmentGO:004654910.2GNAT2, PDE6C
5phototransductionGO:00076029.9GNAT2, OPN1LW, OPN1MW, OPN1SW
6signal transductionGO:00071658.5CNGA3, CNGB3, GNAT2, OPN1LW, OPN1MW, OPN1SW
7response to stimulusGO:00508967.6CNGA3, CNGB3, CNNM4, GNAT2, OPN1LW, OPN1MW
8visual perceptionGO:00076016.0CNGA3, CNGB3, CNNM4, GNAT2, MFRP, OPN1LW

Molecular functions related to Color Blindness according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1intracellular cGMP activated cation channel activityGO:000522310.5CNGA3, CNGB3
2photoreceptor activityGO:000988110.2OPN1LW, OPN1MW, OPN1SW
33,5-cyclic-GMP phosphodiesterase activityGO:004755510.0PDE6C, PDE6H
43,5-cyclic-nucleotide phosphodiesterase activityGO:000411410.0PDE6C, PDE6H
5cGMP bindingGO:00305539.3CNGA3, CNGB3, PDE6C, PDE6H
6signal transducer activityGO:00048719.1GNAT2, OPN1LW, OPN1MW, OPN1SW

Sources for Color Blindness

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet